Literature DB >> 3864916

Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan.

A J Sant, S E Cullen, K S Giacoletto, B D Schwartz.   

Abstract

The murine Ia-associated chondroitin sulfate proteoglycan (CSPG) was studied both biochemically and immunochemically to determine the nature of its core protein. Chondroitinase ABC or chondroitinase AC treatment of the CSPG digested the chondroitin sulfate glycosaminoglycan, yielding a core protein that migrated with an apparent molecular weight of 38,000. Comparative V8 protease digestion of the CSPG core protein and conventional invariant glycoproteins yielded homologous peptides, indicating that the core protein and invariant chain were structurally similar. The purified CSPG and its core protein were both shown to react directly with the monoclonal anti-invariant chain antibody, In-1. Comparative tryptic peptide analysis by high performance liquid chromatography demonstrated coelution of the majority of the peptides from the invariant chain and the CSPG core protein. Collectively, these results indicate that the CSPG is an alternatively processed form of invariant chain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864916      PMCID: PMC2187998          DOI: 10.1084/jem.162.6.1916

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Factors affecting the electrophoretic mobility of the major outer membrane proteins of Escherichia coli in polyacrylamide gels.

Authors:  A P Pugsley; C A Schnaitman
Journal:  Biochim Biophys Acta       Date:  1979-11-23

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  Analysis of HLA-D region-associated molecules with monoclonal antibody.

Authors:  D J Charron; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

4.  Heterogeneity of proteochondroitin sulfates produced by chondrocytes at different stages of cytodifferentiation.

Authors:  K Kimata; M Okayama; A Ooira; S Suzuki
Journal:  J Biol Chem       Date:  1974-03-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Biosynthesis and maturation of HLA-DR antigens in vivo.

Authors:  M J Owen; A M Kissonerghis; H F Lodish; M J Crumpton
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

7.  Analyses of RT1 products using two-dimensional polyacrylamide gels.

Authors:  J G Frelinger; L Hood; P Wettstein
Journal:  Transplant Proc       Date:  1981-06       Impact factor: 1.066

8.  Partial elucidation of an anti-hapten repertoire in BALB/c mice: comparative characterization of several monoclonal anti-fluorescyl antibodies.

Authors:  D M Kranz; E W Voss
Journal:  Mol Immunol       Date:  1981-10       Impact factor: 4.407

9.  Covalent binding of fatty acid to the transferrin receptor in cultured human cells.

Authors:  M B Omary; I S Trowbridge
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

10.  Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis.

Authors:  D A Shackelford; J L Strominger
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Transport and expression of HLA class-II glycoproteins.

Authors:  P Cresswell; J S Blum; J E Davis; M S Marks
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

2.  The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.

Authors:  Lynne S Arneson; Jim Miller
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

3.  The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".

Authors:  M Viguier; K Dornmair; B R Clark; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Naturally occurring mouse antibodies against T-cell-secreted chondroitin sulphate proteoglycan.

Authors:  D Levitt
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

5.  Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins.

Authors:  B Halvorsen; U K Aas; M A Kulseth; C A Drevon; E N Christiansen; S O Kolset
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

Review 6.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  Gene expression of the chondroitin sulfate proteoglycan core protein PG19.

Authors:  M A Bourdon; M Shiga; E Ruoslahti
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  Matrix metalloproteinase-9 in a unique proteoglycan form in avian embryonic growth plate cartilage.

Authors:  R Krishna R Patchigolla; Warren Knudson; Thomas M Schmid
Journal:  Arch Biochem Biophys       Date:  2012-02-13       Impact factor: 4.013

Review 9.  Role of protein glycosylation in immune regulation.

Authors:  E F Hounsell; M J Davies
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

10.  Proteoglycan synthesis in human erythroleukaemia (HEL) cells.

Authors:  B P Schick; S Senkowski-Richardson
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.